Evra contraceptive patch: risks of thromboembolism.
D000279:Administration, Cutaneous; D002170:Canada; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004997:Ethinyl Estradiol / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D005060:Europe; D005260:Female; D006801:Humans; D009644:Norgestrel / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D012306:Risk; D013923:Thromboembolism / Q000139:chemically induced*; D014481:United States; D016387:Women's Health
D003271:Contraceptive Agents, Female; D009644:Norgestrel; D004997:Ethinyl Estradiol